Osaic Holdings’s Lipocine LPCN Stock Holding History

Osaic Holdings’s Portfolio LPCN Stock Details LPCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$609	Buy	238 +95	+66%	+$228	﹤0.01%	7610
2026 Q1	$1.14K	Buy	143 +25	+21%	+$218	﹤0.01%	7225
2025 Q4	$947	Sell	118 -2,150	-95%	-$7.23K	﹤0.01%	7292
2025 Q3	$6.46K	Sell	2,268 -19	-0.8%	-$58	﹤0.01%	6613
2025 Q2	$7.23K	Buy	2,287 +41	+2%	+$133	﹤0.01%	6345
2025 Q1	$7.14K	Buy	2,246 +2,019	+889%	+$7.82K	﹤0.01%	5975
2024 Q4	$1.11K	Hold	227	–	–	﹤0.01%	6811
2024 Q3	$1.02K	Hold	227	–	–	﹤0.01%	6837
2024 Q2	$1.87K	Buy	227 +159	+234%	+$994	﹤0.01%	6621
2024 Q1	$352	Hold	68	–	–	﹤0.01%	6887
2023 Q4	$189	Hold	68	–	–	﹤0.01%	7051
2023 Q3	$201	Hold	68	–	–	﹤0.01%	7152
2023 Q2	$342	Hold	68	–	–	﹤0.01%	7124
2023 Q1	$365	Hold	68	–	–	﹤0.01%	7190
2022 Q4	$0	Hold	68	–	–	﹤0.01%	7330
2022 Q3	$1K	Hold	68	–	–	﹤0.01%	7012
2022 Q2	$1K	Sell	68 -20	-23%	-$312	﹤0.01%	7105
2022 Q1	$2K	Hold	88	–	–	﹤0.01%	6890
2021 Q4	$1K	Sell	88 -871	-91%	-$16.2K	﹤0.01%	7207
2021 Q3	$18K	Hold	959	–	–	﹤0.01%	5849
2021 Q2	$23K	Hold	959	–	–	﹤0.01%	5572
2021 Q1	$25K	Buy	959 +147	+18%	+$4.24K	﹤0.01%	5341
2020 Q4	$19K	Hold	812	–	–	﹤0.01%	5191
2020 Q3	$20K	Hold	812	–	–	﹤0.01%	4913
2020 Q2	$17K	Hold	812	–	–	﹤0.01%	4894
2020 Q1	$7K	Buy	+812	New	+$6.43K	﹤0.01%	5193

Other funds holding LPCN

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Osaic Holdings's LPCN Position: Q2 2026 in Review

Osaic Holdings increased its Lipocine (LPCN) stake by 66% in Q2 2026, buying an estimated $228 and bringing the position to 238 shares worth $609. The position accounts for ﹤0.01% of the portfolio, ranked #7610.

Osaic Holdings first reported a position in LPCN in Q1 2020 and has held it in 26 quarters since. The position peaked at $25K in Q1 2021. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

Osaic Holdings held 238 shares of Lipocine worth $609 as of Q2 2026.
Osaic Holdings bought 95 Lipocine shares in Q2 2026, an estimated $228.
Lipocine made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7610 holding.
Osaic Holdings first reported a position in Lipocine in Q1 2020 and has held it in 26 quarters since.
Osaic Holdings's Lipocine position peaked at $25K in Q1 2021.
36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.